Latest Manufacturing News

ABx Group’s mixed rare earth carbonate from Tasmania’s Deep Leads project has earned strong validation from US-based Rare Earth Technologies Inc, confirming its high purity and compatibility with cutting-edge separation technology.

AdAlta Limited has been granted a key Canadian patent for its anti-fibrotic drug AD-214, completing its composition of matter protection across all major commercial markets. This milestone strengthens the company’s intellectual property portfolio and underpins its commercial strategy for AD-214.

Tivan Limited’s joint venture partners have approved the Feasibility Study for the Speewah Fluorite Project and committed a $5 million equity injection to advance development.

Advanced Energy Minerals is ramping up production capacity at its Quebec plant, leveraging patented low-cost technology and renewable energy to meet booming global demand for high purity alumina.

Theta Gold Mines has locked in a key manufacturing contract for its TGME Gold Project, securing critical equipment that keeps the project on track for commissioning in late 2026 and first gold production early next year.

Imricor Medical Systems has filed a Form 10 registration with the U.S. SEC, marking its transition to a U.S. reporting company amid ongoing FDA clearances and clinical trials. This move signals a significant step in its early commercialisation of MRI-guided cardiac ablation technology.

Austin Engineering has renegotiated its Chile OEM contract, ending losses and setting the stage for profitability and operational turnaround in South America.

Hazer Group has inked a non-binding graphite offtake agreement with Green Steel of WA, marking a significant step in supplying low-emission steel production with up to 85,000 tonnes over 10 years.

EBR Systems marked a pivotal transition in 2025 with FDA approval of its WiSE CRT System and the initiation of U.S. commercial implants, generating $1.6 million in revenue. Despite this progress, the company reported a net loss of $48.8 million and completed a significant capital raise to support ongoing growth.

Austal Limited has addressed ASX concerns over its half-year financial report, confirming compliance with accounting standards despite a qualified audit opinion linked to US Department of Defense contractual relief revenue.

Savana Asset Management’s February letter reveals a challenging month marked by a tech sector sell-off amid AI disruption fears, a surge in AI capital expenditure, and a continuing rotation towards value-driven small caps.

EVE Health Group has increased its placement funding to $1.3 million, backed by a cornerstone investor with pharmaceutical expertise, advancing its reformulated drug programs targeting billion-dollar global markets.